Archived Medical News Stories

RSSArchived Drug Trial News Stories - August 2011

Date Title Comments Rating
2011-08-31 Medivir completes enrollment of three TMC435 phase 3 trials on CHC genotype-1 infection 0 5
2011-08-31 Eisai announces results of perampanel Phase III study on epilepsy 0 None
2011-08-31 Positive results from Bionovo's Menerba tolerability trial on menopausal hot flashes 0 None
2011-08-31 Enrollment commences in Adamis' APC-100 Phase 1/2a clinical prostate study 0 None
2011-08-31 Positive results from Pearl's formoterol fumarate MDI Phase 2b trial on moderate-to-severe COPD 0 None
2011-08-31 Favorable top-line results from Aeterna Zentaris' AEZS-130 Phase 3 study on AGHD 0 None
2011-08-30 Results of Aeterna Zentaris' AEZS-131 anticancer Erk inhibitor presented at ACS 2011 meeting 0 None
2011-08-30 Bristol-Myers Squibb selects ICON as preferred provider for early phase clinical development 0 None
2011-08-30 ZIOPHARM initiates ZIN ATI-001 Phase 1 clinical study in advanced melanoma 0 None
2011-08-30 Results of darexaban phase II trial in recent acute coronary syndrome presented at ESC Congress 0 None
2011-08-30 Bristol Meyer Squibb’s new blood thinner drug for stroke prevention 0 None
2011-08-29 Boehringer Ingelheim initiates two afatinib phase II studies in HER2-positive breast cancer 0 None
2011-08-29 Dabigatran etexilate superior to warfarin for stroke prevention in AF patients 0 2
2011-08-29 Everolimus-eluting stent and SES are equally effective for PCI patients 0 None
2011-08-29 Statins protect people against death from respiratory illness, infections 0 None
2011-08-29 ELIQUIS better than warfarin in reduction of stroke, major bleeding, and mortality 0 None
2011-08-29 Colchicine more effective than placebo for recurrent pericarditis 0 None
2011-08-29 Apixaban superior to warfarin in preventing stroke and systemic embolism 0 None
2011-08-29 Azithromycin can help reduce wheezing, other acute symptoms of COPD 0 None
2011-08-26 BIPI to launch dabigatran etexilate Phase II trial in patients with mechanical heart valves 0 None
2011-08-26 Fludrocortisone may help reduce unexplained chronic nausea in children 0 5
2011-08-26 Nasal spray with hot chili pepper ingredient may help people clear up sinus inflammation 0 None
2011-08-26 Emergent announces results of adjuvanted BioThrax anthrax vaccine Phase 1a trial 0 None
2011-08-25 Lightlake to begin opioid antagonist derived nasal spray Phase II trials in Binge Eating Disorder 0 5
2011-08-25 PLoS One publishes data from recent animal studies of NanoBio's intranasal RSV vaccine 0 None
2011-08-25 Azithromycin can effectively reduce acute COPD exacerbations 0 None
2011-08-24 Psoriasis drug and heart attack risk association unclear: Study 0 None
2011-08-24 KFDA approves IND for DP-b99 Phase III MACSI stroke study in Korea 0 None
2011-08-24 Kibow renews exclusive worldwide veterinary licensing and marketing agreement 1 None
2011-08-24 United Therapeutics completes treprostinil diethanolamine Phase 3 trial in PAH 0 None
2011-08-24 Avastin increases tumor response rates in breast cancer patients before surgery 0 None
2011-08-24 Celldex announces key in vivo efficacy results of CDX-1135 in Dense Deposit Disease 0 5
2011-08-24 Seattle Genetics initiates ADCETRIS phase II trial in CD30-positive non-Hodgkin lymphoma 0 4
2011-08-23 Helsinn begins enrollment in anamorelin Phase III trial for NSCLC-associated anorexia/cachexia 0 None
2011-08-23 Pearl selects TransPerfect's Trial Interactive eTMF solution for clinical development programs 0 3
2011-08-23 Spinifex secures AU$6.25 million in expanded Series B funding 0 None
2011-08-23 Symphogen initiates Sym004 Phase 2 trial in squamous cell carcinoma of head and neck cancer 0 1
2011-08-22 Living Cell Technologies xenoimplants first patients in Argentina trial 0 None
2011-08-20 Researchers turn their attention to Chagas disease as developed countries see rise in infection rates 0 None
2011-08-19 VOA News examines ethics of clinical drug testing in African nations 0 None
2011-08-19 Time-release corticosteroid implant effective in treating uveitis 0 None
2011-08-19 Amgen to present data from several Prolia studies at ASBMR 2011 meeting 0 None
2011-08-19 NIH/NINDS awards AMRI to develop pre-clinical drug candidate for spinal muscular atrophy 0 None
2011-08-19 Minocycline, EDTA may combat catheter-related bacterial infections in dialysis patients 0 3
2011-08-19 FDA grants Fast Track designation for DARA's KRN5500 neuropathic pain relief drug 0 None
2011-08-19 Antigen Express provides update on ongoing AE37 Phase 2 trial in breast cancer 0 None
2011-08-18 BTI completes SUGARDOWN human clinical study on blood sugar management 0 None
2011-08-18 New leukemia drug in early clinical testing offers some clues for better treatment 0 None
2011-08-18 FDA approves Mayo Clinic's ovarian and breast cancer vaccines 0 None
2011-08-18 NCRM at Case Western Reserve to host stem cell conference in Cleveland 0 None
2011-08-18 Clinical trials to evaluate and validate infrastructure of P-medicine consortium 0 None
2011-08-18 Endo terminates collaboration and axomadol development program with Grunenthal 0 None
2011-08-18 CEL-SCI receives Chinese patent for Multikine cancer drug 0 None
2011-08-18 Enrollment commences in Allos' FOLOTYN Phase 3 trial for peripheral T-cell lymphoma 0 None
2011-08-17 Emergent commences TRU-016 Phase 1b/2 combination trial in relapsed indolent NHL 0 4
2011-08-17 Clinical trial to assess 6MP drug in women with advanced breast or ovarian cancer 0 None
2011-08-17 GeoVax receives NIH-NIAID grant for HIV/AIDS vaccine program 0 None
2011-08-17 Clinical Trials Partnership Middle East Summit to take place in Dubai 0 None
2011-08-17 Pegloticase can improve clinical outcomes of patients with chronic gout 0 None
2011-08-17 Patient recruitment complete in Kuros' KUR-023 dural sealant European clinical trial 0 None
2011-08-17 FDA clears Inhibikase IkT-001 Phase II trial to treat JCV infection in multiple sclerosis patients 0 None
2011-08-17 Curis initiates CUDC-101 Phase I combination trial in advanced head and neck cancer 0 None
2011-08-16 Patrys product shows activity in multiple myeloma cancer cells 0 None
2011-08-16 LYSOGENE launches the first gene therapy clinical trials in Sanfilippo disease 0 5
2011-08-16 Zinc lozenges might reduce duration of common cold episodes by 40% 0 None
2011-08-16 Pfizer, QIAGEN partner to develop diagnostic-therapeutic combination for NSCLC 0 None
2011-08-16 AVI BioPharma, MDA to initiate exon-51 Phase 2 trial in Duchenne muscular dystrophy 0 None
2011-08-16 Enrollment commences in Omthera's Epanova Phase III trial for hypertriglyceridemia 0 None
2011-08-16 Enrollment commences in RegeneRx RGN-259 Phase 2 trial for dry eye syndrome 0 None
2011-08-16 Toclizumab for juvenile rheumatoid arthritis 0 None
2011-08-15 Starpharma starts bacterial vaginosis prevention study of VivaGel 1 None
2011-08-15 Arrythmia drug may work in stroke prevention: Study 0 1
2011-08-11 Pacira second quarter total revenues increase to $3.6 million 0 None
2011-08-11 Aeras, OETC announce initiation of new TB vaccine Phase IIb trial in patients with HIV 0 None
2011-08-11 Gastroenterology journal publishes results of Lexicon LX1031 Phase 2 trial in IBS 0 None
2011-08-11 Positive results from two ADL5945 Phase 2 studies for opioid-induced constipation 0 None
2011-08-10 Israeli OCS approves $1.7M grant to support PROLOR's hGH-CTP program 0 None
2011-08-10 Glenmark commences Revamilast Phase IIb trial in chronic inflammatory disorders 0 None
2011-08-10 NCI, Pharmacyclics sign CRADA to develop PCI-32765 for blood cancers 0 5
2011-08-10 Current Medical Research & Opinion publishes new data on EVISTA for postmenopausal osteoporosis 0 None
2011-08-10 Trastuzumab drug increases risk of heart problems in elderly breast cancer patients 0 None
2011-08-10 Hydros-TA therapy provides next generation of osteoarthritis relief 0 None
2011-08-10 Enobia raises US$40M through private placement 0 None
2011-08-09 Positive data from Lexicon LX1032 Phase 2 study on carcinoid syndrome 0 None
2011-08-09 Criterium to manage Senesco's SNS01-T Phase Ib/2a multiple myeloma study 0 None
2011-08-09 Lexicon's second quarter revenues decrease 55% to $0.6 million 0 None
2011-08-09 Genentech, Array BioPharma sign oncology agreement for ChK-1 development program 0 None
2011-08-08 22nd Century initiates enrollment in Phase II-B clinical trial of X-22 for smoking cessation 0 None
2011-08-08 Unigene second quarter revenue decreases to $2.5 million 0 None
2011-08-08 Allergan receives positive opinion from Irish Medicines Board for BOTOX 0 None
2011-08-06 VIVUS announces additional data from phase 3 QNEXA studies on obesity 0 None
2011-08-05 Idera second quarter net loss increases to $6.3 million 0 None
2011-08-05 Alexza resubmits AZ-004 NDA for treatment of agitation in schizophrenia patients 0 None
2011-08-05 ESC to produce focused update on AF Guidelines following early termination of PALLAS Trial 0 None
2011-08-05 Takeda, Amylin discontinue pramlintide/metreleptin development program for obesity 0 None
2011-08-05 YM BioSciences reports preclinical results of CYT387 in multiple myeloma 0 None
2011-08-05 FDA grants Orphan Drug Designation to Kamada's AAT product for type 1 diabetes 0 None
2011-08-05 Positive results from Antares Pharma VIBEX MTX clinical study on RA 0 None
2011-08-05 OncoGenex second quarter revenue increases to $1.9 million 0 None
2011-08-04 Dyax initiates ecallantide Phase 2 trial for ACE inhibitor-induced angioedema 0 None
2011-08-04 Palatin confirms initiation of AZD2820 Phase 1 trial in obesity 0 None
2011-08-04 Positive results from hGH-CTP Phase II trial in growth hormone deficient adults 0 None
2011-08-04 NIH-funded study to assess biomarkers in the blood of TBI patients 0 None
2011-08-04 Pharming, Santarus reach SPA agreement with FDA for RHUCIN Phase III trial 0 None
2011-08-03 Acceleron, Celgene enter development collaboration for ACE-536 protein therapeutic to treat anemia 0 None
2011-08-03 Positive results from combination drug trial for late-stage ovarian cancer 0 None
2011-08-03 Risperidone does not appear to reduce military-related PTSD symptoms 0 None
2011-08-03 Memantine drug could boost cognitive function in people with Down syndrome 0 5
2011-08-03 GSK, NPS enter agreement to evaluate ronacaleret in new indications 0 None
2011-08-02 ARIAD reports $47.8 million net loss for second quarter 2011 0 None
2011-08-02 AstraZeneca recruits patients for KODIAC Phase III trial in opioid-induced constipation 1 None
2011-08-02 Positive results from Jennerex JX-594 proof-of-concept trial on metastatic melanoma 0 4
2011-08-02 Insmed receives FDA clinical hold order for ARIKACE phase 3 trials in CF and NTM 0 None
2011-08-02 Can-Fite commences CF101 phase 2/3 trial for treatment of Psoriasis 0 None
2011-08-01 Femta files IND with FDA for FM101 monoclonal antibody against RA 0 None
2011-08-01 Positive results from Alnylam's ALN-VSP Phase I trial for liver cancer 0 None
2011-08-01 Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections 0 None
2011-08-01 Stealth presents Bendavia at AHA's Cardiovascular Scientific Sessions 0 None


118 posts
19 raters